Technologies to better visualize and treat urologic cancers through minimally invasive procedures in the physicians office & hospital
Building a Best-in-class Urologic Oncology Company
Improving outcomes & patient care
Better visualization to help detect bladder cancer
The i/Blue Imaging System™ small, smart, easier-to-use imaging system for improved visualization of bladder cancer
Precision ablation of prostate cancer
The enCAGE Coil™ radiofrequency focal therapy device for precision ablation of soft tissue is being refined for the treatment of prostate cancer
Adaptable technologies for the office setting
Imagin Medical’s technologies will be adapted to additional minimally invasive surgeries such as laparoscopic surgery
Latest Media
22 August 2022
Imagin Medical Announces Acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer and a New $7.25M Convertible Note to Finance Its Development
Imagin Medical Inc., a urologic oncology company, announces: the acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer from TROD Medical NV, a Belgian company…
26 August 2021
Imagin Medical Secures New $3 Million Convertible Note Financing
Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has closed a new Convertible Note offering totaling US$3,000,000…
